Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 21, 2024International Journal of DermatologyOpen Access

Treatment of atopic dermatitis with abrocitinib in real practice in Spain: efficacy and safety results from a 24‐week multicenter study

View Full Paper
Ask AI
Bookmark
Share

Authors

JHJosé Carlos Armario HitaJRJ RodríguezAGAlicia González‐Quesada

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hita et al. (2024) studied this question.

synapsesocial.com/papers/68e63c18b6db6435875ce17ehttps://doi.org/10.1111/ijd.17344
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis)2026
  2. 2Abrocitinib: 1‐Year Real‐Life Experience From the French OMCCI Registry2026
  3. 3Real‐world effectiveness and safety of abrocitinib in 12 Japanese patients with atopic dermatitis and transcriptome analysis with peripheral blood2024 · 15 citations
  4. 4Effectiveness of Abrocitinib in Cyclosporine-Resistant Atopic Dermatitis: A Real-world Experience from the Indian Subcontinent2026
  5. 5Simulating real-world abrocitinib use in atopic dermatitis: results from JADE REAL2026